01:21 PM EST - Isotechnika Pharma Inc. : and privately-held Aurinia Pharmaceuticals Inc. announced today the signing of a Binding Term Sheet for the merger of the two companies, creating a premier clinical stage pharmaceutical company focused on the global nephrology market. Isotechnika Pharma Inc.
shares T.ISA are trading up $0.01 at $0.06.
